Literature DB >> 7944874

Diagnostic interview for genetic studies. Rationale, unique features, and training. NIMH Genetics Initiative.

J I Nurnberger1, M C Blehar, C A Kaufmann, C York-Cooler, S G Simpson, J Harkavy-Friedman, J B Severe, D Malaspina, T Reich.   

Abstract

This article reports on the development and reliability of the Diagnostic Interview for Genetic Studies (DIGS), a clinical interview especially constructed for the assessment of major mood and psychotic disorders and their spectrum conditions. The DIGS, which was developed and piloted as a collaborative effort of investigators from sites in the National Institute of Mental Health (NIMH) Genetics Initiative, has the following additional features: (1) polydiagnostic capacity; (2) a detailed assessment of the course of the illness, chronology of psychotic and mood syndromes, and comorbidity; (3) additional phenomenologic assessments of symptoms; and (4) algorithmic scoring capability. The DIGS is designed to be employed by interviewers who exercise significant clinical judgment and who summarize information in narrative form as well as in ratings. A two-phase test-retest (within-site, between-site) reliability study was carried out for DSM-III-R criteria-based major depression, bipolar disorder, schizophrenia, and schizoaffective disorder. Reliabilities using algorithms were excellent (0.73 to 0.95), except for schizoaffective disorder, for which disagreement on estimates of duration of mood syndromes relative to psychosis reduced reliability. A final best-estimate process using medical records and information from relatives as well as algorithmic diagnoses is expected to be more reliable in making these distinctions. The DIGS should be useful as part of archival data gathering for genetic studies of major affective disorders, schizophrenia, and related conditions.

Entities:  

Mesh:

Year:  1994        PMID: 7944874     DOI: 10.1001/archpsyc.1994.03950110009002

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  696 in total

1.  A schizophrenia-susceptibility locus at 6q25, in one of the world's largest reported pedigrees.

Authors:  E Lindholm; B Ekholm; S Shaw; P Jalonen; G Johansson; U Pettersson; R Sherrington; R Adolfsson; E Jazin
Journal:  Am J Hum Genet       Date:  2001-05-25       Impact factor: 11.025

Review 2.  Schizotaxia: current status and future directions.

Authors:  Ming T Tsuang; William S Stone; Franziska Gamma; Stephen V Faraone
Journal:  Curr Psychiatry Rep       Date:  2003-06       Impact factor: 5.285

3.  Developmental changes in resting-state functional networks among individuals with and without internalizing psychopathologies.

Authors:  Katie L Burkhouse; Jonathan P Stange; Rachel H Jacobs; Runa Bhaumik; Katie L Bessette; Amy T Peters; Natania A Crane; Kayla A Kreutzer; Kate Fitzgerald; Christopher S Monk; Robert C Welsh; K Luan Phan; Scott A Langenecker
Journal:  Depress Anxiety       Date:  2018-12-05       Impact factor: 6.505

4.  Adjunctive cognitive remediation for schizophrenia using yoga: an open, non-randomized trial.

Authors:  Triptish Bhatia; Akhilesh Agarwal; Gyandeepak Shah; Joel Wood; Jan Richard; Raquel E Gur; Ruben C Gur; Vishwajit L Nimgaonkar; Sati Mazumdar; Smita N Deshpande
Journal:  Acta Neuropsychiatr       Date:  2011-08-10       Impact factor: 3.403

5.  Neuronal generator patterns of olfactory event-related brain potentials in schizophrenia.

Authors:  Jürgen Kayser; Craig E Tenke; Dolores Malaspina; Christopher J Kroppmann; Jennifer D Schaller; Andrew Deptula; Nathan A Gates; Jill M Harkavy-Friedman; Roberto Gil; Gerard E Bruder
Journal:  Psychophysiology       Date:  2010-11       Impact factor: 4.016

6.  Altered integrity of the right arcuate fasciculus as a trait marker of schizophrenia: a sibling study using tractography-based analysis of the whole brain.

Authors:  Chen-Hao Wu; Tzung-Jeng Hwang; Yu-Jen Chen; Yun-Chin Hsu; Yu-Chun Lo; Chih-Min Liu; Hai-Gwo Hwu; Chen-Chung Liu; Ming H Hsieh; Yi Ling Chien; Chung-Ming Chen; Wen-Yih Isaac Tseng
Journal:  Hum Brain Mapp       Date:  2014-11-04       Impact factor: 5.038

7.  Shared genetic factors influence risk for bipolar disorder and alcohol use disorders.

Authors:  N Carmiol; J M Peralta; L Almasy; J Contreras; A Pacheco; M A Escamilla; E E M Knowles; H Raventós; D C Glahn
Journal:  Eur Psychiatry       Date:  2013-12-08       Impact factor: 5.361

8.  Evidence for association of bipolar disorder to haplotypes in the 22q12.3 region near the genes stargazin, IFT27 and parvalbumin.

Authors:  Stephanie Nissen; Sherri Liang; Tatyana Shehktman; John R Kelsoe; Tiffany A Greenwood; Caroline M Nievergelt; Rebecca McKinney; Paul D Shilling; Erin N Smith; Nicholas J Schork; Cinnamon S Bloss; John I Nurnberger; Howard J Edenberg; Tatiana Foroud; Daniel L Koller; Elliot S Gershon; Chunyu Liu; Judith A Badner; William A Scheftner; William B Lawson; Evaristus A Nwulia; Maria Hipolito; William Coryell; John Rice; William Byerley; Francis J McMahon; Wade H Berrettini; James B Potash; Peter P Zandi; Pamela B Mahon; Melvin G McInnis; Sebastian Zöllner; Peng Zhang; David W Craig; Szabolics Szelinger; Thomas B Barrett; Thomas G Schulze
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2012-10-04       Impact factor: 3.568

9.  Association of synapsin 2 with schizophrenia in families of Northern European ancestry.

Authors:  Viatcheslav Saviouk; Michael P Moreau; Irina V Tereshchenko; Linda M Brzustowicz
Journal:  Schizophr Res       Date:  2007-09-04       Impact factor: 4.939

10.  C9ORF72 repeat expansions not detected in a group of patients with schizophrenia.

Authors:  Edward D Huey; Peter L Nagy; Laura Rodriguez-Murillo; Masood Manoochehri; Jill Goldman; Jeffrey Lieberman; Maria Karayiorgou; Richard Mayeux
Journal:  Neurobiol Aging       Date:  2012-10-01       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.